Clinical trial
A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches
NCT00391755 · Charlottesville Neuroscience, Other · Terminated
Key facts
| NCT number | NCT00391755 |
|---|---|
| Title | A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches |
| Official title | A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches |
| Lead sponsor | Charlottesville Neuroscience, Other |
| Collaborators | Takeda Pharmaceuticals North America, Inc. Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Migraine Headache |
| Intervention type | Drug |
| Interventions | ramelteon |
| Enrollment | 4 |
| Start date | Oct 1, 2006 |
| Primary completion | Oct 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Oct 24, 2006 |
| Last update posted | Feb 10, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: